SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-15-033783
Filing Date
2015-05-04
Accepted
2015-05-05 16:13:21
Documents
6
Effectiveness Date
2015-05-04

Document Format Files

Seq Description Document Type Size
1 S-8 a15-10568_1s8.htm S-8 485622
2 EX-5.1 a15-10568_1ex5d1.htm EX-5.1 8774
3 EX-10.1 a15-10568_1ex10d1.htm EX-10.1 88373
4 EX-23.1 a15-10568_1ex23d1.htm EX-23.1 4456
5 GRAPHIC g105681kki001.jpg GRAPHIC 5164
6 GRAPHIC g105681kki002.jpg GRAPHIC 3493
  Complete submission text file 0001104659-15-033783.txt   600471
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-203867 | Film No.: 15833117
SIC: 2834 Pharmaceutical Preparations